一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Cell Death and Differentiation >>article
Cell Death and Differentiation

Cell Death and Differentiation

IF: 15.4
Download PDF

GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62

Published:20 May 2025 DOI: 10.1038/s41418-025-01528-1
Rong Gong, Xiaoya Wan, Shilong Jiang, Yidi Guan, Yizhi Li, Ting Jiang, Zonglin Chen, Changxin Zhong, Linhao He, Zhongyuan Xiang, Junya Yang, Biao Xu, Jinming Yang, Yan Cheng

Abstract

Emerging evidence indicates that activation of ferroptosis by inhibition of glutathione peroxidase 4 (GPX4) may be exploited as a therapeutic strategy to suppress tumor growth and progression. However, application of GPX4 inhibitors in cancer treatment is hampered by their poor selectivity, which results in unfavorable toxicity. Herein, we identified GPX4 as a candidate for the autophagy pathway. We showed that GPX4 is ubiquitinated by TNF receptor-associated factor 6 (TRAF6), which promotes its recognition by p62 and leads to its selective autophagic degradation. Utilizing targeted protein degradation (TPD) approach, we developed a GPX4-targeted AUTAC and demonstrated that GPX4-AUTAC promoted the ubiquitination of GPX4, and enhanced the binding with GPX4 and p62, leading to the selective autophagy-dependent degradation of GPX4. Furthermore, GPX4-AUTAC treatment strongly induced ferroptosis and exhibited potent anti-cancer activity against breast cancer in vitro, in vivo, and patient-derived organoids (PDOs). Combination treatment of GPX4-AUTAC with sulfasalazine, a ferroptotic inducer, or chemotherapy drugs showed a synergistic anti-cancer effect against breast cancer. These results uncover a new targeted degradation strategy for GPX4 by inducing selective autophagy and provide a rationale for the use of GPX4-AUTAC as a novel therapeutic approach to treatment of breast cancer.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
PYR 41 418805-02-4 C17H13N3O7 137 suppliers $16.00-$3040.00
PYR 41 418805-02-4 C17H13N3O7 137 suppliers $16.00-$3040.00
PYR 41 418805-02-4 C17H13N3O7 137 suppliers $16.00-$3040.00
PYR 41 418805-02-4 C17H13N3O7 137 suppliers $16.00-$3040.00

Similar articles

IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
IF:6.9

5-aza-2′-deoxycytidine induces telomere dysfunction in breast cancer cells

Biomedicine & Pharmacotherapy Sarah Al-dulaimi , Sheila Matta ,etc Published: 26 July 2024
IF:3.7

Selective Photocatalytic Oxidation of Thioanisole on DUT-67(Zr) Mediated by Surface Coordination

Langmuir Yanyang Liu, Junhua Zou,etc Published: 19 February 2020
昌宁县| 临夏县| 鹤山市| 信宜市| 大宁县| 右玉县| 怀来县| 微博| 康定县| 喀什市| 凌源市| 河北省| 德令哈市| 马关县| 文安县| 久治县| 铁力市| 衡阳县| 中超| 鄢陵县| 绥德县| 焉耆| 广安市| 呼和浩特市| 嵊泗县| 昌宁县| 徐州市| 佳木斯市| 基隆市| 石渠县| 桃源县| 平泉县| 武川县| 沁源县| 保定市| 紫阳县| 合山市| 泰州市| 迁安市| 营山县| 延边|